|
US3472859A
(en)
|
1966-11-01 |
1969-10-14 |
Sterling Drug Inc |
1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
|
|
JPS4826772Y1
(2)
|
1969-04-04 |
1973-08-06 |
|
|
|
ATE27451T1
(de)
|
1981-03-24 |
1987-06-15 |
Ciba Geigy Ag |
Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
|
|
US4910327A
(en)
|
1982-05-25 |
1990-03-20 |
American Cyanamid Company |
Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid: dialkyl 3-(substituted)phenylaminobut-2-ene-dioates and methods for the preparation thereof
|
|
US4656283A
(en)
|
1982-05-25 |
1987-04-07 |
American Cyanamid Company |
Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid
|
|
US4710507A
(en)
|
1983-12-22 |
1987-12-01 |
Pfizer Inc. |
Quinolone inotropic agents
|
|
FR2634483B2
(fr)
|
1987-12-29 |
1994-03-04 |
Esteve Labor Dr |
Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
|
|
CA2002864C
(en)
|
1988-11-29 |
1999-11-16 |
Eddy J. E. Freyne |
(1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
|
|
SG64322A1
(en)
|
1991-05-10 |
1999-04-27 |
Rhone Poulenc Rorer Int |
Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
|
US5478832A
(en)
|
1992-05-08 |
1995-12-26 |
The Green Cross Corporation |
Quinoline compounds
|
|
JPH0826772A
(ja)
|
1994-07-22 |
1996-01-30 |
Sony Corp |
融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法
|
|
DE69512495T2
(de)
|
1994-10-27 |
2000-02-03 |
Asahi Glass Co. Ltd., Tokio/Tokyo |
Verfahren zur Herstellung von Chinolin-2-yl-benzoesäure
|
|
GB9523267D0
(en)
|
1995-11-14 |
1996-01-17 |
Sandoz Ltd |
Organic compounds
|
|
SK283335B6
(sk)
|
1995-12-08 |
2003-06-03 |
Janssen Pharmaceutica N. V. |
(Imidazol-5-yl)metyl-2-chinolinónové deriváty, spôsob a medziprodukty na ich prípravu, ich použitie a farmaceutické kompozície na ich báze
|
|
AU710926B2
(en)
|
1996-05-20 |
1999-09-30 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
|
AU740603B2
(en)
*
|
1997-06-02 |
2001-11-08 |
Janssen Pharmaceutica N.V. |
(imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
|
|
PL341364A1
(en)
|
1997-12-22 |
2001-04-09 |
Upjohn Co |
4-hydroxyqinoline-3-carboxamides and hydrazides as antiviral agents
|
|
FR2776388B1
(fr)
|
1998-03-20 |
2006-04-28 |
Lipha |
Utilisation de recepteurs de la famille ror pour le criblage de substances utiles pour le traitement de l'atherosclerose
|
|
US6399629B1
(en)
|
1998-06-01 |
2002-06-04 |
Microcide Pharmaceuticals, Inc. |
Efflux pump inhibitors
|
|
HRP20000904A2
(en)
*
|
1998-07-06 |
2001-12-31 |
Janssen Pharmaceutica Nv |
Farnesyl protein transferase inhibitors for treating arthropathies
|
|
ID26987A
(id)
|
1998-07-06 |
2001-02-22 |
Janssen Pharmaceutica Nv |
Inhibitor-inhibitor transferase protein farnesil dengan sifat-sifat peka terhadap sinar radiasi in vivo
|
|
JP2000169451A
(ja)
|
1998-09-30 |
2000-06-20 |
Kyorin Pharmaceut Co Ltd |
６，７―ジ置換キノリンカルボン酸誘導体とその付加塩及びそれらの製造方法
|
|
ID29241A
(id)
|
1998-12-23 |
2001-08-16 |
Janssen Pharmaceutica Nv |
Turunan-turunan kinolin teranelasi-1,2
|
|
US6248736B1
(en)
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
|
|
US6248739B1
(en)
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
Quinolinecarboxamides as antiviral agents
|
|
PL349839A1
(en)
|
1999-02-11 |
2002-09-23 |
Pfizer Prod Inc |
Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
|
|
PT1106612E
(pt)
|
1999-11-30 |
2004-06-30 |
Pfizer Prod Inc |
Derivados de quinolina uteis para inibir a farnesil-proteina-transferase
|
|
JP5491681B2
(ja)
|
2000-02-04 |
2014-05-14 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
乳ガンの治療のためのファルネシルタンパク質トランスフェラーゼ阻害剤
|
|
US6838467B2
(en)
|
2000-02-24 |
2005-01-04 |
Janssen Pharmaceutica N. V. |
Dosing regimen
|
|
AU2001244167A1
(en)
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
|
|
JP2003525252A
(ja)
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｈｅｒ２抗体とのファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤
|
|
WO2001064196A2
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with vinca alkaloids
|
|
AU2001252147A1
(en)
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations
|
|
EP1261343A2
(en)
|
2000-02-29 |
2002-12-04 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
|
|
US20030027808A1
(en)
|
2000-02-29 |
2003-02-06 |
Palmer Peter Albert |
Farnesyl protein transferase inhibitor combinations with platinum compounds
|
|
US20030078281A1
(en)
|
2000-02-29 |
2003-04-24 |
Rybak Mary Ellen Margaret |
Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents
|
|
JP2003525239A
(ja)
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
タキサン化合物とのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤
|
|
CA2397448A1
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with further anti-cancer agents
|
|
EP1267871A2
(en)
|
2000-02-29 |
2003-01-02 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
|
|
WO2001064194A2
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with camptothecin compounds
|
|
US6844357B2
(en)
|
2000-05-01 |
2005-01-18 |
Pfizer Inc. |
Substituted quinolin-2-one derivatives useful as antiproliferative agents
|
|
US6525049B2
(en)
|
2000-07-05 |
2003-02-25 |
Pharmacia & Upjohn Company |
Pyrroloquinolones as antiviral agents
|
|
US6624159B2
(en)
|
2000-07-12 |
2003-09-23 |
Pharmacia & Upjohn Company |
Heterocycle carboxamides as antiviral agents
|
|
ATE276262T1
(de)
|
2000-07-12 |
2004-10-15 |
Upjohn Co |
Oxazinochinolone für die behandlung viraler infektionen
|
|
WO2002024682A1
(en)
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
|
|
WO2002024686A2
(en)
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
|
|
US7067531B2
(en)
|
2000-09-25 |
2006-06-27 |
Angibaud Patrick Rene |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
|
|
CZ20031145A3
(cs)
|
2000-10-02 |
2003-12-17 |
Janssen Pharmaceutica N.V. |
Antagonisté metabotropního glutamátového receptoru
|
|
DK1339407T3
(da)
|
2000-11-28 |
2006-08-14 |
Janssen Pharmaceutica Nv |
Farnesylproteintransferaseinhibitorer til behandling af inflammatorisk tarmsygdom
|
|
ES2260316T3
(es)
|
2000-12-27 |
2006-11-01 |
Janssen Pharmaceutica N.V. |
Derivados de quinazolina y quinolina 4-sustituidos que inhiben la farnesil transferasa.
|
|
JP4969016B2
(ja)
|
2001-02-15 |
2012-07-04 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
抗エストロゲン剤とファルネシルプロテイントランスフェラーゼ阻害剤の組み合わせ物
|
|
US6544990B2
(en)
|
2001-03-01 |
2003-04-08 |
Pharmacia & Upjohn Company |
Substituted quinolinecarboxamides as antiviral agents
|
|
EP1390033A1
(en)
|
2001-04-25 |
2004-02-25 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitors for treating cachexia
|
|
EP1412367A4
(en)
|
2001-06-21 |
2006-05-03 |
Ariad Pharma Inc |
NEW CHINOLINE AND ITS USE
|
|
EP1456208A1
(en)
|
2001-12-20 |
2004-09-15 |
PHARMACIA & UPJOHN COMPANY |
Pyridoquinoxaline antivirals
|
|
AU2002350244A1
(en)
|
2001-12-20 |
2003-07-09 |
Pharmacia And Upjohn Company |
Pyridoquinoxaline antivirals
|
|
CA2479109C
(en)
|
2002-03-29 |
2011-08-02 |
Janssen Pharmaceutica N.V. |
Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
|
|
ATE404537T1
(de)
|
2002-08-13 |
2008-08-15 |
Shionogi & Co |
Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
|
|
AU2003262947A1
(en)
|
2002-08-30 |
2004-03-19 |
Pharmacia And Upjohn Company |
Method of preventing or treating atherosclerosis or restenosis
|
|
GB0222516D0
(en)
|
2002-09-27 |
2002-11-06 |
Karobio Ab |
Novel compounds
|
|
RS20060018A
(sr)
|
2003-07-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
Derivati spojenih arila i heteroarila kao modulatori metabolizma u profilaksi i lečenju sa njima povezanih stanja
|
|
BRPI0416206A
(pt)
|
2003-11-20 |
2006-12-26 |
Janssen Pharmaceutica Nv |
2-quinolinonas e 2-quinoxalinonas substituìdas por 6-alquenila e 6-fenilalquila como inibidores de polimerase de poli(adp-ribose)
|
|
SG151249A1
(en)
|
2003-12-05 |
2009-04-30 |
Janssen Pharmaceutica Nv |
6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
|
|
US7652014B2
(en)
|
2003-12-10 |
2010-01-26 |
Janssen Pharmaceutica |
Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
|
|
AU2004298486A1
(en)
|
2003-12-12 |
2005-06-30 |
Wyeth |
Quinolines useful in treating cardiovascular disease
|
|
EA011277B1
(ru)
|
2004-01-23 |
2009-02-27 |
Янссен Фармацевтика Н.В. |
Производные хинолина и их применение в качестве ингибиторов микобактерий
|
|
EA011572B9
(ru)
|
2004-01-29 |
2018-01-31 |
Янссен Фармацевтика Н.В. |
Производные хинолина для применения в качестве микобактериальных ингибиторов
|
|
JP2005225250A
(ja)
|
2004-02-10 |
2005-08-25 |
Murakami Corp |
車載用監視装置
|
|
ATE540936T1
(de)
|
2004-06-30 |
2012-01-15 |
Janssen Pharmaceutica Nv |
Substituierte 2-alkyl-chinazolinonderivate als parp-hemmer
|
|
ES2407813T3
(es)
|
2004-08-04 |
2013-06-14 |
Meiji Seika Pharma Co., Ltd. |
Derivados de quinolina e insecticida que contienen los mismos como constituyente activo
|
|
KR100686531B1
(ko)
|
2004-08-31 |
2007-02-23 |
한국화학연구원 |
히스톤 디아세틸라제 저해활성을 갖는 아릴아미노메틸프로페닐 벤즈하이드록시아마이드 유도체 및 그의 제조방법
|
|
HRP20130399T1
(hr)
|
2004-11-05 |
2013-06-30 |
Janssen Pharmaceutica Nv |
Terapeutska upotreba inhibitora farenziltransferaze i postupci praä†enja njihove efikasnosti
|
|
JO2855B1
(en)
|
2005-08-03 |
2015-03-15 |
شركة جانسين فارماسوتيكا ان. في |
Quinoline derivatives acting as antibacterial agents
|
|
JO2952B1
(en)
|
2005-08-03 |
2016-03-15 |
جانسين فارماسوتيكا ان. في |
Quinoline derivatives acting as antibacterial agents
|
|
WO2007088978A1
(ja)
|
2006-02-03 |
2007-08-09 |
Meiji Seika Kaisha, Ltd. |
新規キノリン誘導体およびこれを有効成分として含有する農園芸用殺菌剤
|
|
US8389739B1
(en)
|
2006-10-05 |
2013-03-05 |
Orphagen Pharmaceuticals |
Modulators of retinoid-related orphan receptor gamma
|
|
KR101083177B1
(ko)
|
2006-10-23 |
2011-11-11 |
에스지엑스 파마슈티컬스, 인코포레이티드 |
트리아졸로-피리다진 단백질 키나제 조정제
|
|
JO3271B1
(ar)
|
2006-12-06 |
2018-09-16 |
Janssen Pharmaceutica Nv |
مشتقات الكوينولين المضادة للجراثيم
|
|
AR065093A1
(es)
|
2007-02-05 |
2009-05-13 |
Merck Frosst Canada Ltd |
Compuestos farmacéuticos inhibidores de la biosintesis de leucotrienos
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
EP2155197A4
(en)
|
2007-03-09 |
2011-10-12 |
Link Medicine Corp |
TREATMENT OF LYSOSOMAL STORAGE DISEASES
|
|
EP2162132A4
(en)
|
2007-05-21 |
2013-01-16 |
Sgx Pharmaceuticals Inc |
Heterocyclic kinase modulators
|
|
CN101143845B
(zh)
|
2007-10-15 |
2010-08-25 |
中国药科大学 |
取代喹啉甲酰胍衍生物、其制备方法及其医药用途
|
|
AU2009205539B2
(en)
|
2008-01-18 |
2013-12-05 |
Allergan.Inc |
Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
|
|
JP2011511056A
(ja)
|
2008-02-05 |
2011-04-07 |
ファイザー・インク |
Ｃｎｓ障害および代謝障害治療のためのピリジニルアミド
|
|
BRPI0912604A2
(pt)
|
2008-05-13 |
2019-09-10 |
Allergan Inc |
quinolinilmetilimidazóis como agentes terapêuticos
|
|
WO2010068296A1
(en)
|
2008-12-11 |
2010-06-17 |
Stiefel Laboratories, Inc. |
Piperazine carboxamidines as antimicrobial agents
|
|
WO2010127208A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
|
CN101899011B
(zh)
|
2009-05-26 |
2013-01-16 |
北京大学 |
氨基二硫代甲酸酯类化合物、其制备方法和应用
|
|
AR077004A1
(es)
|
2009-06-09 |
2011-07-27 |
Hoffmann La Roche |
Compuestos heterociclicos antivirales
|
|
SG176986A1
(en)
|
2009-06-25 |
2012-02-28 |
Amgen Inc |
Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
|
|
CA2771432A1
(en)
|
2009-08-20 |
2011-02-24 |
Novartis Ag |
Heterocyclic oxime compounds
|
|
EP2368886A1
(en)
|
2010-03-01 |
2011-09-28 |
Phenex Pharmaceuticals AG |
Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
|
|
US9101600B2
(en)
|
2010-03-11 |
2015-08-11 |
New York University |
Compounds as RORγt modulators and uses thereof
|
|
CN105962259A
(zh)
|
2010-04-15 |
2016-09-28 |
卓莫赛尔公司 |
用于减小或消除苦味的化合物、组合物和方法
|
|
WO2012064744A2
(en)
*
|
2010-11-08 |
2012-05-18 |
Lycera Corporation |
Tetrahydroquinoline and related bicyclic compounds for inhibition of rorϒ activity and the treatment of disease
|
|
US11179500B2
(en)
|
2011-02-24 |
2021-11-23 |
Emory University |
JAB1 inhibitory compositions for ossification and methods related thereto
|
|
PE20141637A1
(es)
|
2011-04-28 |
2014-11-20 |
Japan Tobacco Inc |
Compuesto de amida y aplicacion farmaceutica para el mismo
|
|
WO2012158784A2
(en)
|
2011-05-16 |
2012-11-22 |
Theodore Mark Kamenecka |
Modulators of the nuclear hormone receptor ror
|
|
GB201118652D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2013064231A1
(en)
|
2011-10-31 |
2013-05-10 |
Phenex Pharmaceuticals Ag |
SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
|
|
EP2800745B1
(en)
|
2011-12-02 |
2020-02-12 |
Phenex Pharmaceuticals AG |
Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|